Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
AB

WKN: A41EYB | ISIN: CNE1000071P9 | Ticker:
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
AB&B BIO-TECH CO LTD JS Chart 1 Jahr
5-Tage-Chart
AB&B BIO-TECH CO LTD JS 5-Tage-Chart

Aktuelle News zur AB&B BIO-TECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiAB&B BIO-TECH-B (02627): VOLUNTARY ANNOUNCEMENT - FINANCIAL PERFORMANCE AND BUSINESS OPERATIONS FOR THE THIRD QUARTER OF 2026 AND CONTINUED SUSPENSION ...1
AB&B BIO-TECH Aktie jetzt für 0€ handeln
FrAB&B BIO-TECH-B (02627): VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY CHINA CDE FOR TETANUS TOXOID ADSORBED VACCINE1
12.10.AB&B BIO-TECH-B (02627): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
12.10.AB&B BIO-TECH-B (02627): (1) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND (2) CONTINUED SUSPENSION OF TRADING1
30.09.AB&B BIO-TECH-B (02627): QUARTERLY UPDATE ON RESUMPTION PROGRESS AND CONTINUED SUSPENSION OF TRADING-
23.09.AB&B BIO-TECH-B (02627): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
23.09.AB&B BIO-TECH-B (02627): (I) RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF FINANCIAL OFFICER (II) NOMINATION OF EXECUTIVE DIRECTORS (III) APPOINTMENT OF ...1
31.08.AB&B BIO-TECH-B (02627): INSIDE INFORMATION: (1) FURTHER DELAY IN PUBLICATION OF ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 AND ...1
30.06.AB&B BIO-TECH-B (02627): QUARTERLY UPDATE ON RESUMPTION PROGRESS; POSTPONEMENT OF THE 2025 ANNUAL GENERAL MEETING; AND CONTINUED SUSPENSION OF TRADING-
23.06.AB&B BIO-TECH-B (02627): VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY CHINA CDE FOR MRNA MPOX VACCINE1
05.06.AB&B BIO-TECH-B (02627): APPOINTMENT OF INDEPENDENT INVESTIGATOR AND INDEPENDENT INTERNAL CONTROL CONSULTANT1
27.05.AB&B BIO-TECH-B (02627): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2
27.05.AB&B BIO-TECH-B (02627): ARTICLES OF ASSOCIATION-
27.05.AB&B BIO-TECH-B (02627): (1) POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2026 (2) ABOLITION OF THE SUPERVISORY COMMITTEE, AMENDMENTS TO ...-
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1